InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Insider track record
ExecutiveDisclosed buys
0
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Browse the complete record of transactions filed by Cowan Elvia, VP Senior. Insider active across 1 company, notably Vaxcyte, Inc.. Cumulatively, 10 reports have been recorded. History available since 1 March 2023. The latest transaction was disclosed on 7 April 2026 (Levée d'options). Regulator: SEC (Form 4). The full history is accessible without signup.
Declarations10 total
3,000 shares@ US$25.920.0011% mcap50.0% of flowCommon StockSEC:0001960048-26-000007
3,000 shares@ US$25.920.0011% mcap50.0% of flowCommon StockSEC:0001960048-26-000007:0
5,379 shares0Common StockSEC:0001649094-25-000041:0
7,716 shares@ US$25.9226.8% of flowCommon StockSEC:0001649094-24-000124:0
5,000 shares@ US$25.9216.5% of flowCommon StockSEC:0001649094-24-000063:0
5,000 shares@ US$25.9216.8% of flowCommon StockSEC:0001649094-24-000036:0
5,000 shares@ US$25.9216.9% of flowCommon StockSEC:0001649094-24-000034:0
5,400 shares0Common StockSEC:0001415889-24-006475:0
627 shares@ US$51.004.2% of flowCommon StockSEC:0001209191-23-048468:0
7,250 shares0Common StockSEC:0001209191-23-015729:0
10 of 10 declarations
About Cowan Elvia
Elvia Cowan is SVP of Finance and CAO at Vaxcyte, Inc. She is responsible for financial management and accounting operations for the company. Elvia plays a key role in overseeing finances and strategic decision-making. Her expertise in finance contributes to the strength and growth of Vaxcyte.
